NCT05612217View on ClinicalTrials.gov

Evaluation of the AIVARIX in Detecting Signs C 1-2 Classes of CVD

CompletedOBSERVATIONAL
Enrollment

433

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

June 1, 2023

Study Completion Date

April 1, 2024

Conditions
Chronic Venous DiseaseCVD
Interventions
OTHER

to estimate Sensitivity and Specificity AIVARIX app in detecting C1 and C2 classes of CVD

to estimate Sensitivity and Specificity of the AI-based AIVARIX app in detecting C1 and C2 classes of CVD in patients who are seeking for professional advice from a phlebologist regarding symptoms and signs suggestive to CVD.

Trial Locations (1)

Unknown

Pirogov Russian National Research Medical University, Moscow

All Listed Sponsors
lead

Servier Russia

INDUSTRY